BioMarin Pharmaceutical | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Bayer EUR 13.74B 2.01B 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Insmed USD 92.82M 11.62M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
United Therapeutics USD 794.4M 58.5M 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



BioMarin Pharmaceutical Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.